Published in Clin Lymphoma on June 01, 2001
The nucleophosmin-anaplastic lymphoma kinase oncogene interacts, activates, and uses the kinase PIKfyve to increase invasiveness. J Biol Chem (2011) 0.83
Brain metastasis of ALK positive anaplastic large cell lymphoma after a long-term disease free survival in an old adult. Int J Clin Exp Pathol (2014) 0.75
Physiological functions of D-amino acid oxidases: from yeast to humans. Cell Mol Life Sci (2007) 1.66
The effect of dietary soy supplementation on hot flushes. Obstet Gynecol (1998) 1.44
Myelodysplastic transformation in a case of essential thrombocythemia treated with pipobroman. Haematologica (1996) 1.38
Immunological study of in vitro maturation of human megakaryocytes. Br J Haematol (1984) 1.32
Myeloid and megakaryocytic properties of K-562 cell lines. Cancer Res (1983) 1.23
Alteration of vimentin intermediate filament expression during differentiation of human hemopoietic cells. EMBO J (1983) 1.22
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol (2004) 1.22
Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases. Am J Pathol (1998) 1.18
Vaccination against hepatitis B in health care workers. Vaccine (2001) 1.07
Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis. Ann Oncol (2011) 1.03
A monoclonal antibody against an erythrocyte ontogenic antigen identifies fetal and adult erythroid progenitors. Blood (1986) 1.01
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. Ann Oncol (2009) 1.01
Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia (1996) 0.98
Carbonic anhydrase I is an early specific marker of normal human erythroid differentiation. Blood (1985) 0.98
Erythroid progenitors in polycythemia vera: demonstration of their hypersensitivity to erythropoietin using serum free cultures. Blood (1982) 0.98
Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes. Blood (1985) 0.96
Transferrin binding to K562 cell line. Effect of heme and sodium butyrate induction. Exp Cell Res (1982) 0.92
Cytogenetic conversion in a case of polycythaemia vera treated with interferon-alpha. Br J Haematol (1994) 0.90
Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab. Crit Rev Oncol Hematol (2001) 0.89
Influence of spontaneous and surgical menopause on atherogenic metabolic risk. Maturitas (1993) 0.88
The menopausal transition: a dynamic approach to the pathogenesis of neurovegetative complaints. Eur J Obstet Gynecol Reprod Biol (1994) 0.87
Normal human serum contains a factor(s) capable of inhibiting megakaryocyte colony formation. Exp Hematol (1982) 0.86
Expression of platelet proteins during maturation of human megakaryocytes and of the K 562/HEL cell lines. Prog Clin Biol Res (1986) 0.85
Immunological characterization of the leukemic megakaryocytic line at light and electron microscopic levels. Leuk Res (1984) 0.85
The syndrome of T8 hyperlymphocytosis: variation in phenotype and cytotoxic activities of granular cells and evaluation of their role in associated neutropenia. Blood (1987) 0.85
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL). Haematologica (1999) 0.84
Presence of the Tn antigen on hematopoietic progenitors from patients with the Tn syndrome. J Clin Invest (1985) 0.84
Bcl-2 oncoprotein expression in acute myeloid leukemia. Haematologica (1995) 0.84
Treatment of pure red cell aplasia by high dose intravenous immunoglobulins. Br J Haematol (1983) 0.83
Human vascular renin-angiotensin system and its functional changes in relation to different sodium intakes. Hypertension (1998) 0.83
Mixed blood chimerism in T cell-depleted bone marrow transplant recipients: evaluation using DNA polymorphisms. Blood (1987) 0.83
Toluene diisocyanate-induced asthma: clinical findings and bronchial responsiveness studies in 113 exposed subjects with work-related respiratory symptoms. J Occup Med (1991) 0.83
Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki-67 and anti-bromo-deoxyuridine monoclonal antibodies. Br J Haematol (1988) 0.83
Prevalence of dermatophytes and yeasts (Candida spp., Malassezia furfur) in HIV patients. A study of former drug addicts. Mycopathologia (1991) 0.82
Molecular cloning, gene structure and expression profile of mouse C1 inhibitor. Eur J Biochem (1998) 0.82
Autoreactive HLA-DR-specific autoreactive T-cell clones: possible regulatory function for B lymphocytes and hematopoietic precursors. Immunol Rev (1990) 0.82
Age-related and vasomotor stimuli-induced changes in renal vascular resistance detected by Doppler ultrasound. Am J Hypertens (1996) 0.82
Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative". Hematol Pathol (1990) 0.82
Primary high-grade mucosa-associated lymphoid tissue-type lymphoma of the cervix presenting as a common endocervical polyp. Arch Pathol Lab Med (2001) 0.82
Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L. Gruppo Italiano Malattie Mieloproliferative Croniche(GIMMC). Haematologica (2000) 0.81
Sinus histiocytosis with massive lymphadenopathy: immunological, cytogenetic and molecular studies. Blut (1990) 0.81
Local and remote ischemia-reperfusion injury is mitigated in mice overexpressing human C1 inhibitor. Eur Surg Res (2004) 0.81
Dietary soy supplementation and phytoestrogen levels. Obstet Gynecol (1999) 0.80
Persistent polyclonal B lymphocytosis: morphological, immunological, cytogenetic and molecular analysis of an Italian case. Leuk Res (2000) 0.80
Influence of estrogens on serum free fatty acid levels in women. J Clin Endocrinol Metab (1990) 0.80
A putative helical cytokine functioning in innate immune signalling in Drosophila melanogaster. Biochim Biophys Acta (2007) 0.79
The role of interferon-alpha in the treatment of myeloproliferative disorders. Curr Pharm Des (1999) 0.79
[The present and future of infections in the domestic environment in Italy]. Ann Ig (2000) 0.79
Distinct genomic events in the myeloid and lymphoid lineages in simultaneous presentation of chronic myeloid leukemia and B-chronic lymphocytic leukemia. Leukemia (2002) 0.79
Short bowel syndrome: experimental approach to increase intestinal surface in rats by gastric homologous acellular matrix. J Pediatr Surg (2000) 0.78
Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission. Cancer (1989) 0.78
Ratios between the abundance of messenger RNA and the corresponding protein of two growth-related genes, c-myc and vimentin, in leukemia blast cells. Cancer Res (1990) 0.78
Uraemic pruritus is not related to plasma histamine concentrations. Clin Exp Dermatol (1995) 0.78
Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma. Haematologica (2001) 0.78
Platelet alpha-granule release in chronic myeloproliferative disorders with thrombocytosis. Scand J Clin Lab Invest (1986) 0.77
Evaluation of bone metabolic markers as indicators of osteopenia in climacteric women. Gynecol Obstet Invest (1992) 0.77
[Styrene-induced occupational asthma and rhinitis]. G Ital Med Lav (1988) 0.77
Castleman's lymphoadenopathy: twenty years of observation. II. Generalized form. Haematologica (1982) 0.77
Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias: relationship to the expression of cell cycle-related genes. Leukemia (1989) 0.77
Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: its relationship to type beta transforming growth factor (TGF-beta). J Cell Physiol (1988) 0.77
In vitro fibroblast and dermis fibroblast activation by laser irradiation at low energy. An electron microscopic study. Dermatologica (1984) 0.77
All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase. Leukemia (1998) 0.77
Plasma lipoproteins in soy-treated postmenopausal women: a double-blind, placebo-controlled trial. Nutr Metab Cardiovasc Dis (2000) 0.76
Primary infection by HHV-6 variant B associated with a fatal case of hemophagocytic syndrome. New Microbiol (1997) 0.76
Low-dose intravenous pepsin-treated gammaglobulin for idiopathic thrombocytopenic purpura in adults. Br J Haematol (1984) 0.76
Ultrastructural and cytochemical characterization of blasts from early erythroblastic leukemias. Leukemia (1987) 0.76
An unstable ribonucleic acid in normal human erythroblasts. Nature (1965) 0.76
In vitro inhibition of hematopoiesis by HNK1, DR-positive T cells and monocytes after allogeneic bone marrow transplantation. Exp Hematol (1987) 0.76
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign. Ann Oncol (1999) 0.76
[Quality of care in nursing homes: a review of literature regarding structure, process and outcome indicators related to the risk of malnutrition]. Ann Ig (2012) 0.76
Local immunotherapy by inhalation of a powder extract in asthma due to house dust mite Dermatophagoides pteronyssinus: a double-blind comparison with parenteral immunotherapy. J Investig Allergol Clin Immunol (1991) 0.76
HCV and monoclonal gammopathies. Clin Exp Rheumatol (1996) 0.76
Reversal of bone marrow hypoplasia in anorexia nervosa: case report. Int J Eat Disord (2000) 0.76
Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis. Leuk Lymphoma (1993) 0.76
Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia. Haematologica (2000) 0.76
Anionic binding site and 2,3-DPG effect in bovine hemoglobin. Biochemistry (1998) 0.76
Music-listening habits with MP3 player in a group of adolescents: a descriptive survey. Ann Ig (2013) 0.75
Trazodone: a non-hormonal alternative for neurovegetative climacteric symptoms. Clin Exp Obstet Gynecol (1995) 0.75
Platelet alpha granule release in diabetes mellitus. Scand J Clin Lab Invest (1985) 0.75
[Ultrastructure of the so-called unicellular sebaceous glands]. G Ital Dermatol Minerva Dermatol (1970) 0.75
Leptomeningeal carcinomatosis presenting as progressive multineuritis: clinical, pathologic, and MRI study. Clin Neuropathol (1996) 0.75
[Histochemical study of the pigmented cell of senile verruca]. Boll Soc Ital Biol Sper (1970) 0.75
Blast crisis of Ph1-CML, with the prevalent features of malignant histiocytosis. Haematologica (1998) 0.75
Castleman's lymphoadenopathy: twenty years of observation. I. General considerations. Monoadenopathic variety. Haematologica (1982) 0.75
[Cytochemical aspects of Grawitz tumor]. Boll Soc Ital Biol Sper (1965) 0.75
Predominantly B-cell infiltrate in rheumatoid nodules. Haematologica (1981) 0.75
[A case of histiocytosis X with atypical histological characters]. Minerva Pediatr (1976) 0.75
[Histochemical studies of the lipids of compound nevus]. Boll Soc Ital Biol Sper (1970) 0.75
Sideroblastic anemia terminating in chronic myeloid leukemia. Am J Hematol (1997) 0.75
[Atypical bone marrow involvement in the course of malignant lymphogranuloma. Report of 2 cases]. Minerva Med (1972) 0.75
[On the relations between mastocytes and nevus cell tumors of the skin]. G Ital Dermatol Minerva Dermatol (1969) 0.75
Hodgkin's disease and non-Hodgkin's lymphomas. Panminerva Med (1981) 0.75
[Malignant lymphogranuloma in otorhinolaryngology. (Review of literature and considerations on a case with primary maxillofacial localization)]. Clin Otorinolaringoiatr (1969) 0.75
[Tuberculous lymphadenitis. Apropos of a non-typical histological picture]. Minerva Med (1984) 0.75
[Lipids of the cells of the basal layer of the epidermis of the eyelid]. G Ital Dermatol Minerva Dermatol (1970) 0.75
[Complex pathogenesis of a systemic hemopathy: hairy cell leukemia]. Haematologica (1985) 0.75
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics]. Pathologica (2006) 0.75